NCT02199652View on ClinicalTrials.gov

Reducing Suicidal Ideation Through Treatment of Nightmares-Post Traumatic Stress Disorder (PTSD)

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

September 1, 2017

Study Completion Date

December 1, 2017

Conditions
Post Traumatic Stress DisorderSuicidal IdeationNightmares
Interventions
DRUG

Prazosin

DRUG

Placebo

Trial Locations (1)

30912

Georgia Regents University, Augusta

All Listed Sponsors
lead

Augusta University

OTHER

NCT02199652 - Reducing Suicidal Ideation Through Treatment of Nightmares-Post Traumatic Stress Disorder (PTSD) | Biotech Hunter | Biotech Hunter